Benzinga's Top Ratings Upgrades, Downgrades For January 27, 2023

Loading...
Loading...

Upgrades

For Plexus Corp PLXS, Sidoti & Co. upgraded the previous rating of Neutral to Buy. For the first quarter, Plexus had an EPS of $1.49, compared to year-ago quarter EPS of $0.88. The current stock performance of Plexus shows a 52-week-high of $115.36 and a 52-week-low of $72.88. Moreover, at the end of the last trading period, the closing price was at $93.86.

For Take-Two Interactive Software Inc TTWO, MoffettNathanson upgraded the previous rating of Market Perform to Outperform. Take-Two Interactive earned $1.30 in the second quarter, compared to $1.63 in the year-ago quarter. The current stock performance of Take-Two Interactive shows a 52-week-high of $178.50 and a 52-week-low of $90.00. Moreover, at the end of the last trading period, the closing price was at $111.89.

Argus Research upgraded the previous rating for Las Vegas Sands Corp LVS from Hold to Buy. In the fourth quarter, Las Vegas Sands showed an EPS of $0.19, compared to $0.22 from the year-ago quarter. The stock has a 52-week-high of $58.89 and a 52-week-low of $28.88. At the end of the last trading period, Las Vegas Sands closed at $58.37.

According to Credit Suisse, the prior rating for Premier Inc PINC was changed from Underperform to Neutral. In the first quarter, Premier showed an EPS of $0.52, compared to $0.64 from the year-ago quarter. The stock has a 52-week-high of $38.98 and a 52-week-low of $30.82. At the end of the last trading period, Premier closed at $32.92.

For Cabaletta Bio Inc CABA, Morgan Stanley upgraded the previous rating of Equal-Weight to Overweight. In the third quarter, Cabaletta Bio showed an EPS of $0.39, compared to $0.45 from the year-ago quarter. At the moment, the stock has a 52-week-high of $11.97 and a 52-week-low of $0.59. Cabaletta Bio closed at $10.45 at the end of the last trading period.

Morgan Stanley upgraded the previous rating for Akero Therapeutics Inc AKRO from Equal-Weight to Overweight. In the third quarter, Akero Therapeutics showed an EPS of $0.92, compared to $0.70 from the year-ago quarter. At the moment, the stock has a 52-week-high of $54.88 and a 52-week-low of $7.52. Akero Therapeutics closed at $47.65 at the end of the last trading period.

Wedbush upgraded the previous rating for Chewy Inc CHWY from Neutral to Outperform. In the third quarter, Chewy showed an EPS of $0.01, compared to $0.08 from the year-ago quarter. The current stock performance of Chewy shows a 52-week-high of $54.19 and a 52-week-low of $22.22. Moreover, at the end of the last trading period, the closing price was at $43.97.

For Vir Biotechnology Inc VIR, Morgan Stanley upgraded the previous rating of Underweight to Equal-Weight. In the third quarter, Vir Biotechnology showed an EPS of $1.30, compared to $0.82 from the year-ago quarter. At the moment, the stock has a 52-week-high of $35.48 and a 52-week-low of $18.05. Vir Biotechnology closed at $29.99 at the end of the last trading period.

Jefferies upgraded the previous rating for Viatris Inc VTRS from Hold to Buy. For the third quarter, Viatris had an EPS of $0.87, compared to year-ago quarter EPS of $0.99. The current stock performance of Viatris shows a 52-week-high of $15.60 and a 52-week-low of $8.42. Moreover, at the end of the last trading period, the closing price was at $11.64.

Bernstein upgraded the previous rating for McCormick & Co Inc MKC from Market Perform to Outperform. McCormick & Co earned $0.73 in the fourth quarter, compared to $0.84 in the year-ago quarter. The stock has a 52-week-high of $107.35 and a 52-week-low of $71.19. At the end of the last trading period, McCormick & Co closed at $73.46.

Piper Sandler upgraded the previous rating for Iovance Biotherapeutics Inc IOVA from Neutral to Overweight. In the third quarter, Iovance Biotherapeutics showed an EPS of $0.63, compared to $0.55 from the year-ago quarter. At the moment, the stock has a 52-week-high of $18.73 and a 52-week-low of $5.42. Iovance Biotherapeutics closed at $7.69 at the end of the last trading period.

See all analyst ratings upgrades.

Downgrades

According to OTR Global, the prior rating for Ralph Lauren Corp RL was changed from Positive to Mixed. Ralph Lauren earned $2.23 in the second quarter, compared to $2.62 in the year-ago quarter. The current stock performance of Ralph Lauren shows a 52-week-high of $135.99 and a 52-week-low of $82.23. Moreover, at the end of the last trading period, the closing price was at $124.21.

For Playtika Holding Corp PLTK, DA Davidson downgraded the previous rating of Buy to Neutral. Playtika Holding earned $0.17 in the third quarter, compared to $0.20 in the year-ago quarter. At the moment, the stock has a 52-week-high of $21.45 and a 52-week-low of $7.81. Playtika Holding closed at $10.31 at the end of the last trading period.

UBS downgraded the previous rating for Confluent Inc CFLT from Buy to Neutral. Confluent earned $0.13 in the third quarter, compared to $0.17 in the year-ago quarter. The current stock performance of Confluent shows a 52-week-high of $81.11 and a 52-week-low of $16.48. Moreover, at the end of the last trading period, the closing price was at $22.26.

UBS downgraded the previous rating for Polaris Inc PII from Buy to Neutral. Polaris earned $3.25 in the third quarter, compared to $1.98 in the year-ago quarter. The current stock performance of Polaris shows a 52-week-high of $127.37 and a 52-week-low of $91.86. Moreover, at the end of the last trading period, the closing price was at $106.46.

Wolfe Research downgraded the previous rating for Northrop Grumman Corp NOC from Outperform to Peer Perform. In the fourth quarter, Northrop Grumman showed an EPS of $7.50, compared to $6.00 from the year-ago quarter. At the moment, the stock has a 52-week-high of $556.27 and a 52-week-low of $364.62. Northrop Grumman closed at $443.47 at the end of the last trading period.

For Ralph Lauren Corp RL, BMO Capital downgraded the previous rating of Market Perform to Underperform. Ralph Lauren earned $2.23 in the second quarter, compared to $2.62 in the year-ago quarter. The current stock performance of Ralph Lauren shows a 52-week-high of $135.99 and a 52-week-low of $82.23. Moreover, at the end of the last trading period, the closing price was at $124.21.

For Aveanna Healthcare Holdings Inc AVAH, Credit Suisse downgraded the previous rating of Neutral to Underperform. For the third quarter, Aveanna Healthcare Hldgs had an EPS of $0.03, compared to year-ago quarter EPS of $0.11. The stock has a 52-week-high of $6.00 and a 52-week-low of $0.67. At the end of the last trading period, Aveanna Healthcare Hldgs closed at $1.31.

According to Wolfe Research, the prior rating for Alaska Air Group Inc ALK was changed from Outperform to Peer Perform. Alaska Air Gr earned $0.92 in the fourth quarter, compared to $0.24 in the year-ago quarter. The current stock performance of Alaska Air Gr shows a 52-week-high of $61.55 and a 52-week-low of $38.19. Moreover, at the end of the last trading period, the closing price was at $51.32.

According to BTIG, the prior rating for Datadog Inc DDOG was changed from Buy to Neutral. Datadog earned $0.23 in the third quarter, compared to $0.13 in the year-ago quarter. At the moment, the stock has a 52-week-high of $184.70 and a 52-week-low of $61.34. Datadog closed at $76.00 at the end of the last trading period.

For Y-mAbs Therapeutics Inc YMAB, Morgan Stanley downgraded the previous rating of Equal-Weight to Underweight. For the third quarter, Y-mAbs Therapeutics had an EPS of $0.63, compared to year-ago quarter EPS of $0.66. The current stock performance of Y-mAbs Therapeutics shows a 52-week-high of $20.48 and a 52-week-low of $2.94. Moreover, at the end of the last trading period, the closing price was at $4.55.

According to Morgan Stanley, the prior rating for Taysha Gene Therapies Inc TSHA was changed from Overweight to Equal-Weight. In the third quarter, Taysha Gene Therapies showed an EPS of $0.64, compared to $1.35 from the year-ago quarter. The current stock performance of Taysha Gene Therapies shows a 52-week-high of $8.93 and a 52-week-low of $1.35. Moreover, at the end of the last trading period, the closing price was at $1.85.

For Teradyne Inc TER, Loop Capital downgraded the previous rating of Buy to Hold. Teradyne earned $0.92 in the fourth quarter, compared to $1.37 in the year-ago quarter. The stock has a 52-week-high of $147.94 and a 52-week-low of $67.81. At the end of the last trading period, Teradyne closed at $103.67.

Mizuho downgraded the previous rating for Fortinet Inc FTNT from Buy to Neutral. For the third quarter, Fortinet had an EPS of $0.33, compared to year-ago quarter EPS of $0.20. The stock has a 52-week-high of $357.58 and a 52-week-low of $42.61. At the end of the last trading period, Fortinet closed at $53.21.

For Northrop Grumman Corp NOC, Cowen & Co. downgraded the previous rating of Outperform to Market Perform. Northrop Grumman earned $7.50 in the fourth quarter, compared to $6.00 in the year-ago quarter. At the moment, the stock has a 52-week-high of $556.27 and a 52-week-low of $364.62. Northrop Grumman closed at $443.47 at the end of the last trading period.

For Origin Bancorp Inc OBNK, Piper Sandler downgraded the previous rating of Overweight to Neutral. For the fourth quarter, Origin Bancorp had an EPS of $0.99, compared to year-ago quarter EPS of $1.20. The current stock performance of Origin Bancorp shows a 52-week-high of $47.28 and a 52-week-low of $35.36. Moreover, at the end of the last trading period, the closing price was at $38.96.

Loading...
Loading...

Goldman Sachs downgraded the previous rating for Steel Dynamics Inc STLD from Buy to Neutral. For the fourth quarter, Steel Dynamics had an EPS of $4.37, compared to year-ago quarter EPS of $5.78. The stock has a 52-week-high of $121.76 and a 52-week-low of $52.26. At the end of the last trading period, Steel Dynamics closed at $121.44.

According to Goldman Sachs, the prior rating for Hess Corp HES was changed from Buy to Neutral. For the fourth quarter, Hess had an EPS of $1.78, compared to year-ago quarter EPS of $0.85. The stock has a 52-week-high of $160.52 and a 52-week-low of $86.42. At the end of the last trading period, Hess closed at $160.44.

Piper Sandler downgraded the previous rating for Bridgewater Bancshares Inc BWB from Overweight to Neutral. For the fourth quarter, Bridgewater Bancshares had an EPS of $0.45, compared to year-ago quarter EPS of $0.39. At the moment, the stock has a 52-week-high of $20.20 and a 52-week-low of $14.97. Bridgewater Bancshares closed at $16.35 at the end of the last trading period.

For CBRE Group Inc CBRE, Keefe, Bruyette & Woods downgraded the previous rating of Outperform to Market Perform. In the third quarter, CBRE Group showed an EPS of $1.13, compared to $1.39 from the year-ago quarter. The current stock performance of CBRE Group shows a 52-week-high of $106.60 and a 52-week-low of $66.31. Moreover, at the end of the last trading period, the closing price was at $84.10.

See all analyst ratings downgrades.

Initiations

Citigroup initiated coverage on CBRE Group Inc CBRE with a Buy rating. The price target for CBRE Group is set to $100.00. In the third quarter, CBRE Group showed an EPS of $1.13, compared to $1.39 from the year-ago quarter. The stock has a 52-week-high of $106.60 and a 52-week-low of $66.31. At the end of the last trading period, CBRE Group closed at $84.10.

UBS initiated coverage on Karuna Therapeutics Inc KRTX with a Neutral rating. The price target for Karuna Therapeutics is set to $209.00. Karuna Therapeutics earned $2.38 in the third quarter, compared to $1.72 in the year-ago quarter. At the moment, the stock has a 52-week-high of $278.25 and a 52-week-low of $92.26. Karuna Therapeutics closed at $196.08 at the end of the last trading period.

Citigroup initiated coverage on Jones Lang LaSalle Inc JLL with a Neutral rating. The price target for Jones Lang LaSalle is set to $200.00. In the third quarter, Jones Lang LaSalle showed an EPS of $3.40, compared to $4.56 from the year-ago quarter. At the moment, the stock has a 52-week-high of $264.40 and a 52-week-low of $135.35. Jones Lang LaSalle closed at $181.94 at the end of the last trading period.

With a Buy rating, Citigroup initiated coverage on Bill.com Holdings Inc BILL. The price target seems to have been set at $131.00 for Bill.com Holdings. For the first quarter, Bill.com Holdings had an EPS of $0.14, compared to year-ago quarter EPS of $0.15. The current stock performance of Bill.com Holdings shows a 52-week-high of $262.17 and a 52-week-low of $89.87. Moreover, at the end of the last trading period, the closing price was at $113.43.

Berenberg initiated coverage on CNH Industrial NV CNHI with a Buy rating. The price target for CNH Industrial is set to $31.00. CNH Industrial earned $0.41 in the third quarter, compared to $0.34 in the year-ago quarter. The current stock performance of CNH Industrial shows a 52-week-high of $17.53 and a 52-week-low of $10.60. Moreover, at the end of the last trading period, the closing price was at $17.44.

With an Overweight rating, Piper Sandler initiated coverage on Prothena Corp PLC PRTA. The price target seems to have been set at $94.00 for Prothena Corp. For the third quarter, Prothena Corp had an EPS of $0.97, compared to year-ago quarter EPS of $2.13. The stock has a 52-week-high of $66.47 and a 52-week-low of $21.06. At the end of the last trading period, Prothena Corp closed at $55.85.

With a Buy rating, Guggenheim initiated coverage on Confluent Inc CFLT. The price target seems to have been set at $29.00 for Confluent. In the third quarter, Confluent showed an EPS of $0.13, compared to $0.17 from the year-ago quarter. The current stock performance of Confluent shows a 52-week-high of $81.11 and a 52-week-low of $16.48. Moreover, at the end of the last trading period, the closing price was at $22.26.

Guggenheim initiated coverage on MongoDB Inc MDB with a Neutral rating. The price target for MongoDB is set to $205.00. MongoDB earned $0.23 in the third quarter, compared to $0.03 in the year-ago quarter. At the moment, the stock has a 52-week-high of $471.96 and a 52-week-low of $135.15. MongoDB closed at $208.23 at the end of the last trading period.

For Teradata Corp TDC, Guggenheim initiated coverage, by setting the current rating at Neutral. Teradata earned $0.31 in the third quarter, compared to $0.43 in the year-ago quarter. The current stock performance of Teradata shows a 52-week-high of $52.53 and a 52-week-low of $28.65. Moreover, at the end of the last trading period, the closing price was at $34.50.

Guggenheim initiated coverage on Informatica Inc INFA with a Buy rating. The price target for Informatica is set to $24.00. In the third quarter, Informatica showed an EPS of $0.18, compared to $0.23 from the year-ago quarter. The current stock performance of Informatica shows a 52-week-high of $30.50 and a 52-week-low of $14.96. Moreover, at the end of the last trading period, the closing price was at $17.36.

With a Buy rating, Guggenheim initiated coverage on Couchbase Inc BASE. The price target seems to have been set at $20.00 for Couchbase. For the third quarter, Couchbase had an EPS of $0.22, compared to year-ago quarter EPS of $0.29. At the moment, the stock has a 52-week-high of $25.03 and a 52-week-low of $10.19. Couchbase closed at $14.33 at the end of the last trading period.

Guggenheim initiated coverage on CommVault Systems Inc CVLT with a Buy rating. The price target for CommVault Systems is set to $86.00. In the second quarter, CommVault Systems showed an EPS of $0.57, compared to $0.48 from the year-ago quarter. The current stock performance of CommVault Systems shows a 52-week-high of $69.96 and a 52-week-low of $50.26. Moreover, at the end of the last trading period, the closing price was at $60.90.

With a Buy rating, Stifel initiated coverage on Compass Therapeutics Inc CMPX. The price target seems to have been set at $9.00 for Compass Therapeutics. In the third quarter, Compass Therapeutics showed an EPS of $0.12, compared to $0.10 from the year-ago quarter. At the moment, the stock has a 52-week-high of $5.65 and a 52-week-low of $1.25. Compass Therapeutics closed at $3.95 at the end of the last trading period.

With a Buy rating, Benchmark initiated coverage on Standex International Corp SXI. The price target seems to have been set at $150.00 for Standex International. For the first quarter, Standex International had an EPS of $1.60, compared to year-ago quarter EPS of $1.34. The stock has a 52-week-high of $112.26 and a 52-week-low of $79.02. At the end of the last trading period, Standex International closed at $108.52.

Benchmark initiated coverage on Driven Brands Holdings Inc DRVN with a Buy rating. The price target for Driven Brands Hldgs is set to $40.00. In the third quarter, Driven Brands Hldgs showed an EPS of $0.32, compared to $0.26 from the year-ago quarter. The stock has a 52-week-high of $35.45 and a 52-week-low of $24.62. At the end of the last trading period, Driven Brands Hldgs closed at $28.06.

See all analyst ratings initiations.

Loading...
Loading...
Market News and Data brought to you by Benzinga APIs
date
ticker
name
Price Target
Upside/Downside
Recommendation
Firm
Posted In: UpgradesDowngradesInitiationIntraday UpdateAnalyst RatingsBZI-Ratings
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!

Loading...